- High Density Lipoprotein: A Therapeutic Target in Type 2 Diabetes
-
Barter PJ
- KMID: 1973820
- Endocrinol Metab.
- 2013 Sep;28(3):169-177.
- doi: 10.3803/EnM.2013.28.3.169
High density lipoproteins (HDLs) have a number of properties that have the potential to inhibit the development of atherosclerosis and thus reduce the risk of having a cardiovascular event. These... -
- CITED
-
- Close
- SHARE
-
- Close
- The Causes and Consequences of Low Levels of High Density Lipoproteins in Patients with Diabetes
-
Barter PJ
- KMID: 2281707
- Diabetes Metab J.
- 2011 Apr;35(2):101-106.
- doi: 10.4093/dmj.2011.35.2.101
Type 2 diabetes is commonly accompanied by a low level of high density lipoprotein cholesterol (HDL-C) that contributes to the increased cardiovascular risk associated with this condition. Given that HDLs... -
- CITED
-
- Close
- SHARE
-
- Close
